Chemistry Meets Biology in Colitis-associated Carcinogenesis

Overview

Journal Free Radic Res

Publisher Informa Healthcare

Specialty Biochemistry

Date 2013 Aug 10

PMID 23926919

Citations 26

Authors

A Mangerich

P C Dedon

J G Fox

S R Tannenbaum

G N Wogan

Affiliations

Soon will be listed here.

Abstract

The intestine comprises an exceptional venue for a dynamic and complex interplay of numerous chemical and biological processes. Here, multiple chemical and biological systems, including the intestinal tissue itself, its associated immune system, the gut microbiota, xenobiotics, and metabolites meet and interact to form a sophisticated and tightly regulated state of tissue homoeostasis. Disturbance of this homeostasis can cause inflammatory bowel disease (IBD)-a chronic disease of multifactorial etiology that is strongly associated with increased risk for cancer development. This review addresses recent developments in research into chemical and biological mechanisms underlying the etiology of inflammation-induced colon cancer. Beginning with a general overview of reactive chemical species generated during colonic inflammation, the mechanistic interplay between chemical and biological mediators of inflammation, the role of genetic toxicology, and microbial pathogenesis in disease development are discussed. When possible, we systematically compare evidence from studies utilizing human IBD patients with experimental investigations in mice. The comparison reveals that many strong pathological and mechanistic correlates exist between mouse models of colitis-associated cancer, and the clinically relevant situation in humans. We also summarize several emerging issues in the field, such as the carcinogenic potential of novel inflammation-related DNA adducts and genotoxic microbial factors, the systemic dimension of inflammation-induced genotoxicity, and the complex role of genome maintenance mechanisms during these processes. Taken together, current evidence points to the induction of genetic and epigenetic alterations by chemical and biological inflammatory stimuli ultimately leading to cancer formation.

Citing Articles

Redox regulation: mechanisms, biology and therapeutic targets in diseases.

Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.

PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.

Protective effect of (E)-(2,4-dihydroxy)-α-aminocinnamic acid, a hydroxy cinnamic acid derivative, in an ulcerative colitis model induced by TNBS.

Rivera Antonio A, Padilla Martinez I, Marquez-Flores Y, Juarez Solano A, Torres Ramos M, Rosales Hernandez M Biosci Rep. 2024; 44(10).

PMID: 39268608 PMC: 11461179. DOI: 10.1042/BSR20240797.

5-Chloro-2'-deoxycytidine Induces a Distinctive High-Resolution Mutational Spectrum of Transition Mutations In Vivo.

Chancharoen M, Yang Z, Dalvie E, Gubina N, Ruchirawat M, Croy R Chem Res Toxicol. 2024; 37(3):486-496.

PMID: 38394377 PMC: 10952010. DOI: 10.1021/acs.chemrestox.3c00358.

Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease.

Sahoo D, Heilmann R, Paital B, Patel A, Yadav V, Wong D Front Endocrinol (Lausanne). 2023; 14:1217165.

PMID: 37701897 PMC: 10493311. DOI: 10.3389/fendo.2023.1217165.

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Blagov A, Orekhova V, Sukhorukov V, Melnichenko A, Orekhov A Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37631065 PMC: 10458684. DOI: 10.3390/ph16081150.

References

Kamizato M, Nishida K, Masuda K, Takeo K, Yamamoto Y, Kawai T . Interleukin 10 inhibits interferon gamma- and tumor necrosis factor alpha-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon. J Gastroenterol. 2009; 44(12):1172-84. DOI: 10.1007/s00535-009-0119-6. View

Wu X, Takenaka K, Sonoda E, Hochegger H, Kawanishi S, Kawamoto T . Critical roles for polymerase zeta in cellular tolerance to nitric oxide-induced DNA damage. Cancer Res. 2006; 66(2):748-54. DOI: 10.1158/0008-5472.CAN-05-2884. View

Issa J, Ahuja N, Toyota M, Bronner M, Brentnall T . Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61(9):3573-7. View

Goodman J, Hofseth L, Hussain S, Harris C . Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen. 2004; 44(1):3-9. DOI: 10.1002/em.20024. View

Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y . Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut. 1998; 42(2):180-7. PMC: 1727005. DOI: 10.1136/gut.42.2.180. View

Kim M, Lim C, Trudel L, Deen W, Wogan G . Delivery method, target gene structure, and growth properties of target cells impact mutagenic responses to reactive nitrogen and oxygen species. Chem Res Toxicol. 2012; 25(4):873-83. PMC: 3328651. DOI: 10.1021/tx2004882. View

Singer I, Kawka D, Scott S, Weidner J, Mumford R, Riehl T . Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996; 111(4):871-85. DOI: 10.1016/s0016-5085(96)70055-0. View

Valinluck V, Liu P, Kang Jr J, Burdzy A, Sowers L . 5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2). Nucleic Acids Res. 2005; 33(9):3057-64. PMC: 1140371. DOI: 10.1093/nar/gki612. View

Muthupalani S, Ge Z, Feng Y, Rickman B, Mobley M, McCabe A . Systemic macrophage depletion inhibits Helicobacter bilis-induced proinflammatory cytokine-mediated typhlocolitis and impairs bacterial colonization dynamics in a BALB/c Rag2-/- mouse model of inflammatory bowel disease. Infect Immun. 2012; 80(12):4388-97. PMC: 3497414. DOI: 10.1128/IAI.00530-12. View

10.

Godschalk R, Albrecht C, Curfs D, Schins R, Bartsch H, van Schooten F . Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice. Mutat Res. 2007; 621(1-2):87-94. DOI: 10.1016/j.mrfmmm.2007.02.012. View

11.

Nathan C . Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006; 6(3):173-82. DOI: 10.1038/nri1785. View

12.

Te Velde A, Pronk I, de Kort F, Stokkers P . Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?. Eur J Gastroenterol Hepatol. 2008; 20(6):555-60. DOI: 10.1097/MEG.0b013e3282f45751. View

13.

Burmer G, Rabinovitch P, Haggitt R, Crispin D, Brentnall T, Kolli V . Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology. 1992; 103(5):1602-10. DOI: 10.1016/0016-5085(92)91184-6. View

14.

Venkatesan B, Bashir R . Nanopore sensors for nucleic acid analysis. Nat Nanotechnol. 2011; 6(10):615-24. DOI: 10.1038/nnano.2011.129. View

15.

Hoffman R, Zhang G, Nussler N, Gleixner S, Ford H, Simmons R . Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol. 1997; 272(2 Pt 1):G383-92. DOI: 10.1152/ajpgi.1997.272.2.G383. View

16.

Son J, Pang B, McFaline J, Taghizadeh K, Dedon P . Surveying the damage: the challenges of developing nucleic acid biomarkers of inflammation. Mol Biosyst. 2008; 4(9):902-8. DOI: 10.1039/b719411k. View

17.

Korzenik J, Podolsky D . Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov. 2006; 5(3):197-209. DOI: 10.1038/nrd1986. View

18.

Takizawa S, Aratani Y, Fukuyama N, Maeda N, Hirabayashi H, Koyama H . Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain. J Cereb Blood Flow Metab. 2002; 22(1):50-4. DOI: 10.1097/00004647-200201000-00006. View

19.

Soehnlein O, Lindbom L . Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010; 10(6):427-39. DOI: 10.1038/nri2779. View

20.

Laval F, Wink D . Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis. 1994; 15(3):443-7. DOI: 10.1093/carcin/15.3.443. View